Quanex Building Products Announces Second Quarter 2024 Results and Reaffirms Full Year 2024 Guidance

Rhea-AI Summary

Quanex Building Products (NYSE:NX) announced its Q2 2024 results, showing net sales of $266.2 million, down 2.7% YoY. The decrease was due to weaker market demand in its European Fenestration and North American Cabinet Components segments. Despite this, the company achieved margin expansion in North America. Net income was $15.4 million, down from $21.5 million YoY. Diluted EPS was $0.46, a decrease from $0.65. Adjusted Net Income remained stable at $21.8 million, and Adjusted Diluted EPS was unchanged at $0.66. Quanex repaid $10 million in bank debt, leaving no outstanding draws on its revolver. The company reaffirmed its FY 2024 guidance, projecting net sales of around $1.1 billion and Adjusted EBITDA of $145-$150 million.

Positive

• Margin expansion in North America.
• No outstanding draws on revolver after repaying $10 million in bank debt.
• Adjusted Net Income stable at $21.8 million.
• Adjusted Diluted EPS unchanged at $0.66.
• Reaffirmed FY 2024 guidance with net sales projected at $1.1 billion.
• Adjusted EBITDA projected at $145-$150 million for FY 2024.

Negative

• Net sales down 2.7% YoY to $266.2 million.
• Net income decreased to $15.4 million from $21.5 million YoY.
• Diluted EPS fell to $0.46 from $0.65 YoY.
• Lower volumes and pricing pressure in European Fenestration segment.
• Decline in net sales in North American Cabinet Components segment by 4.6%.

Insights

Financial Analyst

Quanex Building Products' second quarter results provide several key takeaways for retail investors. Despite a slight decrease in net sales to $266.2 million from $273.5 million year-over-year, the company managed to improve its gross margin slightly to 24.9%. This shows effective cost management, especially given the drop in raw material costs.

While North American volumes increased, driven by normal seasonality, the European market struggled due to low consumer confidence. The mixed regional performance underscores the importance of market diversification but also poses a risk due to dependence on regional economic conditions.

Another key highlight is the reaffirmation of full-year guidance. This indicates management’s confidence in achieving its financial goals despite current market uncertainties. The debt repayment of $10 million and being net debt-free is a strong positive signal for financial health, potentially reducing interest expenses and freeing up cash for future investments.

Investors should note the stable Adjusted EBITDA Margin of 15% for the quarter, reflecting operational efficiency. However, the slight decline in adjusted net income and diluted EPS year-over-year suggests that while the company is managing well, it's not immune to broader market pressures.

Overall, the company's performance shows resilience and prudent fiscal management, making it a stable investment, but future growth may hinge on macroeconomic conditions, especially in Europe.

Market Research Analyst

The announcement reinforces Quanex's strategic positioning in the building products sector. The detailed breakout of regional performance provides invaluable insights. North American Fenestration's 1.8% sales increase highlights growing demand in a core segment, while the 4.6% decline in North American Cabinet Components due to lower volumes and pricing setbacks indicates potential market saturation or competitive pressures.

The European market's 10.4% sales decrease, exacerbated by pricing pressure and volume drops, serves as a stark reminder of the ongoing consumer confidence issues in the region. This persistent challenge could impact future earnings if not managed properly.

The company's decision to reaffirm its full-year guidance amid such mixed performance suggests a cautious optimism based on current market trends and customer feedback. This cautious approach is prudent given the complexities and volatilities of the global market.

For retail investors, understanding these market segment performances is crucial. They should monitor how the company navigates these regional challenges and leverages areas of growth, particularly in North America. The upcoming acquisition of Tyman, expected in the second half of 2024, could be a significant factor, potentially enhancing market position and financial performance if integrated effectively.

Margin Expansion in North America and on a Consolidated Basis
Repaid $10 Million in Bank Debt – No Outstanding Draws on Revolver
Tyman Acquisition Expected to Close in 2H24

HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2024.  

The Company reported the following selected financial results:

	Three Months Ended April 30,				Six Months Ended April 30,
($ in millions, except per share data)	2024		2023		2024		2023
Net Sales	$266.2		$273.5		$505.4		$535.5
Gross Margin	$66.2		$67.2		$117.7		$118.9
Gross Margin %	24.9%		24.6%		23.3%		22.2%
Net Income	$15.4		$21.5		$21.6		$23.4
Diluted EPS	$0.46		$0.65		$0.65		$0.71
Adjusted Net Income	$21.8		$21.7		$27.6		$27.8
Adjusted Diluted EPS	$0.66		$0.66		$0.83		$0.84
Adjusted EBITDA	$40.0		$39.9		$59.3		$60.4
Adjusted EBITDA Margin %	15.0%		14.6%		11.7%		11.3%
Cash Provided by Operating Activities	$33.1		$35.3		$36.9		$38.5
Free Cash Flow	$25.5		$27.8		$19.8		$23.4

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Our second quarter results came in as expected and we continue to execute. Volumes in North America increased in the second quarter compared to the first quarter of the year, which is encouraging and follows normal seasonality in our business. Volumes in Europe were challenged during the quarter as low consumer confidence continues to impact demand. However, we continue to operate efficiently and were able to realize margin expansion in both of our North American operating segments and on a consolidated basis for the second quarter of 2024. Our continued focus on generating cash and managing working capital enabled us to pay down the remaining $10 million balance on our revolver.”

Second Quarter 2024 Results Summary

Quanex reported net sales of $266.2 million during the three months ended April 30, 2024, which represents a decrease of 2.7% compared to $273.5 million for the same period of 2023. The decrease was largely attributable to softer market demand in the Company’s European Fenestration and North American Cabinet Components segments. Quanex reported a 1.8% increase in net sales for the second quarter in its North American Fenestration segment primarily due to improved volume. In its North American Cabinet Components segment, the Company reported a decline of 4.6% in net sales for the second quarter as a result of lower volume and decreased pricing related to raw material index pricing mechanisms. Excluding foreign exchange impact, Quanex realized a decrease in net sales of 10.4% for the second quarter in its European Fenestration segment mainly due to lower volume and pricing pressure. (See Sales Analysis table for additional information)

The increase in adjusted earnings for the three months ended April 30, 2024 was mostly attributable to a decline in raw material costs, lower income tax expense and lower interest expense.

Balance Sheet Update

As of April 30, 2024, Quanex had total debt of $55.2 million (primarily finance leases) and the Company’s leverage ratio of Net Debt to LTM Adjusted EBITDA continued to improve and Quanex is Net Debt free. As of April 30, 2024, the Company’s LTM Net Income was $80.7 million and LTM Adjusted EBITDA was $158.5 million.   (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Outlook

Mr. Wilson stated, “As expected, we are starting to see a seasonal uptick in the demand for our products in North America. Market dynamics in Europe continue to be challenging and volumes are soft; however, we are performing well, and our business is resilient. Based on results to date, conversations with our customers, recent demand trends, and the latest macro data, we are reaffirming our prior guidance for fiscal 2024. On a consolidated basis, we continue to estimate net sales of approximately $1.1 billion, which should result in approximately $145 million to $150 million of Adjusted EBITDA* in fiscal 2024.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

Recent Events

As previously disclosed on April 22, 2024, Quanex announced it had reached agreement with Tyman plc (LSE:TYMN) (“Tyman”) on the terms of a recommended cash and share offer (the “Acquisition”), under which Quanex will acquire the entire issued and to be issued share capital of Tyman for approximately $1.1 billion in enterprise value. The full terms and conditions of the Acquisition are set out in a joint announcement released on April 22, 2024 under Rule 2.7 of the UK Takeover Code. A copy of this announcement is available on the Quanex website at https://www.roadto2b.com, subject to certain access restrictions. The Acquisition has been unanimously approved by the Boards of Directors of both Quanex and Tyman and is currently expected to close in the second half of the calendar year 2024, subject to the satisfaction of customary closing conditions, including shareholder approval from both Tyman and Quanex shareholders and regulatory approvals.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, June 7, 2024 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI8e90696b55d04353a1f5e63939f8a6f6

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration, custom mixing and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the Acquisition, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

Important Additional Information will be Filed with the SEC

In connection with the Acquisition, Quanex filed with the U.S. Securities and Exchange Commission (the “SEC”) a definitive proxy statement on June 6, 2024 (the “Proxy Statement”). Before making any voting decision, Quanex’s stockholders are urged to read the Proxy Statement and other relevant documents filed or to be filed with the SEC in connection with the Acquisition or incorporated by reference in the Proxy Statement carefully and in their entirety because they contain important information about the Acquisition and the share issuance proposal. Quanex’s stockholders and investors will be able to obtain, without charge, a copy of the Proxy Statement and other relevant documents filed with the SEC from the SEC’s website at http://www.sec.gov or directing a written request to Quanex (Attention: Investor Relations), at 945 Bunker Hill Road, Suite 900, Houston, Texas 77024 or from Quanex’s website at https://investors.quanex.com.

No Offer or Solicitation

The information contained in this press release is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. In particular, this press release is not an offer of securities for sale into the United States or in any other jurisdiction. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. Any securities issued in the Acquisition are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the Securities Act. The Acquisition will be made solely by means of the scheme document to be published by Tyman in due course, or (if applicable) pursuant to an offer document to be published by Quanex, which (as applicable) would contain the full terms and conditions of the Acquisition. Any decision in respect of, or other response to, the Acquisition, should be made only on the basis of the information contained in such document(s) and the Proxy Statement. If, in the future, Quanex ultimately seeks to implement the Acquisition by way of a takeover offer or otherwise in a manner that is not exempt from the registration requirements of the Securities Act, that offer will be made in compliance with applicable US laws and regulations.

This press release does not constitute a prospectus or a prospectus exempted document.

Participants in the Solicitation

Quanex and certain of its directors and executive officers and employees may be considered participants in the solicitation of proxies from the stockholders of Quanex in respect of the Acquisition, including the share issuance proposal. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the stockholders of Quanex in connection with the Acquisition, including a description of their direct or indirect interests, by security holdings or otherwise, are set forth in the Proxy Statement. Additional information regarding Quanex’s directors and executive officers is contained in Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023 and its annual meeting proxy statement on Schedule 14A, dated January 25, 2024, which are filed with the SEC.

UK Takeover Code: Profit Forecast

UK Takeover Code

The Acquisition referred to in the paragraph entitled “Recent Events” above is governed by the UK's City Code on Takeovers and Mergers (the “UK Takeover Code”). In accordance with the rules of the UK Takeover Code, Quanex is required to publish certain confirmations in connection with the information set out in this release. These confirmations are set out below.

Quanex Profit Forecast

The following statement in this press release (the “Quanex Profit Forecast”) constitutes an ordinary course profit forecast for the purposes of Rule 28.1(a) and Note 2(b) on Rule 28.1 of the UK Takeover Code:    

“As expected, we are starting to see a seasonal uptick in the demand for our products in North America. Market dynamics in Europe continue to be challenging and volumes are soft; however, we are performing well, and our business is resilient. Based on results to date, conversations with our customers, recent demand trends, and the latest macro data, we are reaffirming our prior guidance for fiscal 2024. On a consolidated basis, we continue to estimate net sales of approximately $1.1 billion, which should result in approximately $145 million to $150 million of Adjusted EBITDA* in fiscal 2024.

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.”

References to “GAAP” in the Quanex Profit Forecast are to U.S. GAAP, being the accounting policies applied in the preparation of the Quanex group’s annual results for the fiscal year ended October 31, 2023.

Basis of preparation

The Quanex Profit Forecast has been prepared on a basis consistent with Quanex’s accounting policies, as set out in the paragraph entitled “Non-GAAP Terminology Definitions and Disclaimers”.

The Quanex Profit Forecast excludes any transaction costs applicable to the Acquisition or any other associated accounting impacts as a direct result of the Acquisition.

Assumptions

The Quanex Profit Forecast is based on the assumptions listed below, any of which could turn out to be incorrect and therefore affect the validity of the Quanex Profit Forecast.

• There are no material changes to the prevailing macroeconomic or political conditions in the markets and regions in which the Quanex group operates.
• There will be no material changes to the conditions of the markets and regions in which the Quanex group operates or in relation to customer sales volume or product mix or the behaviour of competitors in those markets and regions.
• There are no material changes to the Quanex group’s cost base throughout the fiscal year.
• There will be no material changes in foreign exchange rates that will have a significant impact on the Quanex group’s revenue or cost base.
• The interest, inflation and tax rates in the markets and regions in which the Quanex group operates will remain materially unchanged from the prevailing rates.
• There will be no business disruptions that materially affect the Quanex group or its key customers, including natural disasters, acts of terrorism, cyber-attack and/or technological issues or supply chain disruptions.
• There will be no material changes in legislation or regulatory requirements impacting on the Quanex group’s operations or on its accounting policies.
• There will be no material litigation in relation to any of the Quanex group’s operations.
• The Acquisition will not result in any material changes to the Quanex group’s obligations to customers.
• The Acquisition will not have any material impact on the Quanex group’s ability to negotiate new business.
• There will be no material change to the present executive management of the Quanex group.
• There will be no material change in the operational strategy of the Quanex group.
• There will be no material acquisitions or disposals in the relevant period.
• There will be no material strategic investments in the relevant period.
• There will be no material change in the dividend or capital policies of the Quanex group.
• The Quanex Profit Forecast does not include any impact on the Quanex group of the Acquisition.

Other important factors and information are contained in Quanex’s most recent Annual Report on Form 10-K, including the risks summarised in the section entitled “Risk Factors”, Quanex’s most recent Quarterly Report on Form 10-Q, and Quanex’s other periodic filings with the SEC and available at https://investors.quanex.com/.

Quanex Directors’ confirmation

With the consent of Tyman, the UK's Panel on Takeovers and Mergers has granted a dispensation from the UK Takeover Code requirement for Quanex’s reporting accountants and financial advisers to prepare reports in respect of the Quanex Profit Forecast.

The Quanex Directors have considered the Quanex Profit Forecast and confirm that it has been properly compiled on the basis of the assumptions set out in this release and that the basis of the accounting used is consistent with Quanex’s accounting policies.

No Profit Forecasts or Estimates

The Quanex Profit Forecast is a profit forecast for the purposes of Rule 28 of the UK Takeover Code.

Other than in respect of the Quanex Profit Forecast, no statement in this release is intended as, or is to be construed as, a profit forecast or profit estimate for any period and no statement in this release should be interpreted to mean that earnings or earnings per unit of common stock for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per unit of common stock.

For the purposes of Rule 28 of the UK Takeover Code, the Quanex Profit Forecast contained in this release is the responsibility of Quanex and the Quanex Directors.

Publication on Website

A copy of this release will be made available on Quanex’s website at https://www.roadto2b.com/ by no later than 12 noon (London time) on the business day following the date of this release. Neither the contents of that website nor the content of any other website accessible from hyperlinks on such website is incorporated into, or forms part of, this release.

CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME
(In thousands, except per share data)
(Unaudited)
		Three Months Ended April 30,								Six Months Ended April 30,
		2024				2023				2024				2023
Net sales		$	266,201			$	273,535			$	505,356			$	535,451
Cost of sales			199,963				206,372				387,686				416,521
Selling, general and administrative			34,707				27,371				67,070				64,115
Depreciation and amortization			10,894				10,456				22,046				21,076
Operating income			20,637				29,336				28,554				33,739
Interest expense			(950	)			(2,244	)			(2,018	)			(4,503	)
Other, net			4				(29	)			1,046				189
Income before income taxes			19,691				27,063				27,582				29,425
Income tax expense			(4,314	)			(5,551	)			(5,956	)			(6,004	)
Net income		$	15,377			$	21,512			$	21,626			$	23,421
Earnings per common share, basic		$	0.47			$	0.65			$	0.66			$	0.71
Earnings per common share, diluted		$	0.46			$	0.65			$	0.65			$	0.71
Weighted average common shares outstanding:
Basic			32,870				32,858				32,847				32,905
Diluted			33,103				33,017				33,076				33,070
Cash dividends per share		$	0.08			$	0.08			$	0.16			$	0.16

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
		April 30, 2024				October 31, 2023
ASSETS
Current assets:
Cash and cash equivalents		$	56,149			$	58,474
Accounts receivable, net			87,078				97,311
Inventories			101,446				97,959
Income taxes receivable			6,054				8,298
Prepaid and other current assets			12,776				11,558
Total current assets			263,503				273,600
Property, plant and equipment, net			252,857				250,664
Operating lease right-of-use assets			65,019				46,620
Goodwill			184,481				182,956
Intangible assets, net			68,667				74,115
Other assets			2,686				3,188
Total assets		$	837,213			$	831,143
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable		$	60,615			$	74,371
Accrued liabilities			48,851				50,319
Income taxes payable			-				384
Current maturities of long-term debt			2,632				2,365
Current operating lease liabilities			6,433				7,224
Total current liabilities			118,531				134,663
Long-term debt			51,549				66,435
Noncurrent operating lease liabilities			59,965				40,361
Deferred income taxes			29,280				29,133
Other liabilities			11,766				14,997
Total liabilities			271,091				285,589
Stockholders’ equity:
Common stock			371				372
Additional paid-in-capital			249,502				251,576
Retained earnings			425,650				409,318
Accumulated other comprehensive loss			(34,631	)			(38,141	)
Treasury stock at cost			(74,770	)			(77,571	)
Total stockholders’ equity			566,122				545,554
Total liabilities and stockholders' equity		$	837,213			$	831,143

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
	Six Months Ended April 30,
	2024				2023
Operating activities:
Net income	$	21,626			$	23,421
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		22,046				21,076
Stock-based compensation		1,365				1,398
Deferred income tax		(155	)			97
Other, net		162				982
Changes in assets and liabilities:
Decrease in accounts receivable		10,832				11,564
(Increase) decrease in inventory		(3,008	)			14,799
Increase in other current assets		(1,124	)			(1,746	)
Decrease in accounts payable		(12,619	)			(19,825	)
Decrease in accrued liabilities		(4,602	)			(14,407	)
Increase (decrease) in income taxes payable		1,856				(1,754	)
Increase in deferred pension benefits		-				17
Increase in other long-term liabilities		9				1,808
Other, net		557				1,030
Cash provided by operating activities		36,945				38,460
Investing activities:
Business acquisition		-				(91,302	)
Capital expenditures		(17,183	)			(15,074	)
Proceeds from disposition of capital assets		93				101
Cash used for investing activities		(17,090	)			(106,275	)
Financing activities:
Borrowings under credit facilities		-				102,000
Repayments of credit facility borrowings		(15,000	)			(35,000	)
Repayments of other long-term debt		(954	)			(1,306	)
Common stock dividends paid		(5,294	)			(5,320	)
Issuance of common stock		554				99
Payroll tax paid to settle shares forfeited upon vesting of stock		(1,193	)			(567	)
Purchase of treasury stock		-				(5,593	)
Cash (used for) provided by financing activities		(21,887	)			54,313
Effect of exchange rate changes on cash and cash equivalents		(293	)			1,905
Decrease in cash and cash equivalents		(2,325	)			(11,597	)
Cash and cash equivalents at beginning of period		58,474				55,093
Cash and cash equivalents at end of period	$	56,149			$	43,496

QUANEX BUILDING PRODUCTS CORPORATION FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited)
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
	Three Months Ended April 30,				Six Months Ended April 30,
	2024		2023		2024		2023
Cash provided by operating activities	$33,091		$35,325		$36,945		$38,460
Capital expenditures	(7,603)		(7,492)		(17,183)		(15,074)
Free Cash Flow	$25,488		$27,833		$19,762		$23,386
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
	As of April 30,
	2024		2023
Revolving credit facility	$0		$80,000
Finance lease obligations(1)	55,217		55,626
Total debt(2)	55,217		135,626
Less: Cash and cash equivalents	56,149		43,496
Net Debt	($932)		$92,130
(1) Includes $51.0 million and $53.1 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30, 2024 and April 30, 2023, respectively.
(2) Excludes outstanding letters of credit.

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
Reconciliation of Last Twelve Months Adjusted EBITDA		Three Months Ended April 30, 2024				Three Months Ended January 31, 2024				Three Months Ended October 31, 2023				Three Months Ended July 31, 2023				Total
		Reconciliation				Reconciliation				Reconciliation				Reconciliation				Reconciliation
Net income as reported		$	15,377			$	6,249			$	27,382			$	31,698			$	80,706
Income tax expense			4,314				1,642				4,442				4,099				14,497
Other, net			(4	)			(1,042	)			6,110				(402	)			4,662
Interest expense			950				1,068				1,565				2,068				5,651
Depreciation and amortization			10,894				11,152				11,194				10,596				43,836
EBITDA			31,531				19,069				50,693				48,059				149,352
Cost of sales(1),(2)			631				-				(35	)			-				596
Selling, general and administrative(1),(2),(3)			7,862				205				109				395				8,571
Adjusted EBITDA		$	40,024			$	19,274			$	50,767			$	48,454			$	158,519
(1) Expense related to plant closure.
(2) Loss on damage to manufacturing facilities caused by weather.
(3) Transaction and advisory fees.

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
Reconciliation of Adjusted Net Income and Adjusted EPS		Three Months Ended April 30, 2024								Three Months Ended April 30, 2023								Six Months Ended April 30, 2024								Six Months Ended April 30, 2023
		Net Income				Diluted EPS				Net Income				Diluted EPS				Net Income				Diluted EPS				Net Income				Diluted EPS
Net income as reported		$	15,377			$	0.46			$	21,512			$	0.65			$	21,626			$	0.65			$	23,421			$	0.71
Net income reconciling items from below			6,409			$	0.20				195			$	0.01				5,974			$	0.18				4,349			$	0.13
Adjusted net income and adjusted EPS		$	21,786			$	0.66			$	21,707			$	0.66			$	27,600			$	0.83			$	27,770			$	0.84
Reconciliation of Adjusted EBITDA		Three Months Ended April 30, 2024								Three Months Ended April 30, 2023								Six Months Ended April 30, 2024								Six Months Ended April 30, 2023
		Reconciliation								Reconciliation								Reconciliation								Reconciliation
Net income as reported		$	15,377							$	21,512							$	21,626							$	23,421
Income tax expense			4,314								5,551								5,956								6,004
Other, net			(4	)							29								(1,046	)							(189	)
Interest expense			950								2,244								2,018								4,503
Depreciation and amortization			10,894								10,456								22,046								21,076
EBITDA			31,531								39,792								50,600								54,815
EBITDA reconciling items from below			8,493								111								8,698								5,559
Adjusted EBITDA		$	40,024							$	39,903							$	59,298							$	60,374
Reconciling Items		Three Months Ended April 30, 2024								Three Months Ended April 30, 2023								Six Months Ended April 30, 2024								Six Months Ended April 30, 2023
		Income Statement				Reconciling Items				Income Statement				Reconciling Items				Income Statement				Reconciling Items				Income Statement				Reconciling Items
Net sales		$	266,201			$	-			$	273,535			$	-			$	505,356			$	-			$	535,451			$	-
Cost of sales			199,963				(631	)	(1)		206,372				(48	)	(2)		387,686				(631	)	(1)		416,521				(48	)	(2)
Selling, general and administrative			34,707				(7,862	)	(1), (3)		27,371				(63	)	(2), (3)		67,070				(8,067	)	(1), (3)		64,115				(5,511	)	(2), (3)
EBITDA			31,531				8,493				39,792				111				50,600				8,698				54,815				5,559
Depreciation and amortization			10,894				-				10,456				-				22,046				-				21,076				-
Operating income			20,637				8,493				29,336				111				28,554				8,698				33,739				5,559
Interest expense			(950	)			-				(2,244	)			-				(2,018	)			-				(4,503	)			-
Other, net			4				(92	)	(4)		(29	)			132		(4)		1,046				(847	)	(4)		189				90		(4)
Income before income taxes			19,691				8,401				27,063				243				27,582				7,851				29,425				5,649
Income tax expense			(4,314	)			(1,992	)	(5)		(5,551	)			(48	)	(5)		(5,956	)			(1,877	)	(5)		(6,004	)			(1,300	)	(4)
Net income		$	15,377			$	6,409			$	21,512			$	195			$	21,626			$	5,974			$	23,421			$	4,349
Diluted earnings per share		$	0.46							$	0.65							$	0.65							$	0.71
(1) Expense related to plant closure.
(2) Loss on damage to manufacturing facilities caused by weather.
(3) Transaction and advisory fees.
(4) Pension settlement (refund) expense and foreign currency transaction losses (gains).
(5)Tax impact of net income reconciling items.

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
		NA Fenestration				EU Fenestration				NA Cabinet Components				Unallocated Corp & Other				Total
Three months ended April 30, 2024
Net sales		$	159,774			$	56,583			$	51,078			$	(1,234	)		$	266,201
Cost of sales			122,261				35,694				42,624				(616	)			199,963
Gross Margin			37,513				20,889				8,454				(618	)			66,238
Gross Margin %			23.5	%			36.9	%			16.6	%							24.9	%
Selling, general and administrative(1)			13,730				7,873				5,066				8,038				34,707
Depreciation and amortization			5,218				2,538				3,082				56				10,894
Operating income (loss)			18,565				10,478				306				(8,712	)			20,637
Depreciation and amortization			5,218				2,538				3,082				56				10,894
EBITDA			23,783				13,016				3,388				(8,656	)			31,531
Expense related to plant closure (Cost of sales)							-				631				-				631
Expense related to plant closure (SG&A)			-				-				978				-				978
Transaction and advisory fees			-				-				-				6,884				6,884
Adjusted EBITDA		$	23,783			$	13,016			$	4,997			$	(1,772	)		$	40,024
Adjusted EBITDA Margin %			14.9	%			23.0	%			9.8	%							15.0	%
Three months ended April 30, 2023
Net sales		$	156,975			$	63,763			$	53,518			$	(721	)		$	273,535
Cost of sales			122,472				40,452				43,731				(283	)			206,372
Gross Margin			34,503				23,311				9,787				(438	)			67,163
Gross Margin %			22.0	%			36.6	%			18.3	%							24.6	%
Selling, general and administrative(1)			14,158				8,452				5,971				(1,210	)			27,371
Depreciation and amortization			5,050				2,353				2,970				83				10,456
Operating income			15,295				12,506				846				689				29,336
Depreciation and amortization			5,050				2,353				2,970				83				10,456
EBITDA			20,345				14,859				3,816				772				39,792
Loss on damage to manufacturing facilities (Cost of sales)			35				-				13				-				48
Loss on damage to manufacturing facilities (SG&A)			-				-				200				-				200
Transaction and advisory fees			-				-				-				(137	)			(137	)
Adjusted EBITDA		$	20,380			$	14,859			$	4,029			$	635			$	39,903
Adjusted EBITDA Margin %			13.0	%			23.3	%			7.5	%							14.6	%
Six months ended April 30, 2024
Net sales		$	307,769			$	106,020			$	94,215			$	(2,648	)		$	505,356
Cost of sales			240,629				67,397				81,367				(1,707	)			387,686
Gross Margin			67,140				38,623				12,848				(941	)			117,670
Gross Margin %			21.8	%			36.4	%			13.6	%							23.3	%
Selling, general and administrative(1)			29,640				15,618				10,192				11,620				67,070
Depreciation and amortization			10,693				5,096				6,147				110				22,046
Operating income (loss)			26,807				17,909				(3,491	)			(12,671	)			28,554
Depreciation and amortization			10,693				5,096				6,147				110				22,046
EBITDA			37,500				23,005				2,656				(12,561	)			50,600
Expense related to plant closure (Cost of sales)			-				-				631				-				631
Expense related to plant closure (SG&A)			-				-				978				-				978
Transaction and advisory fees			-				-				-				7,089				7,089
Adjusted EBITDA		$	37,500			$	23,005			$	4,265			$	(5,472	)		$	59,298
Adjusted EBITDA Margin %			12.2	%			21.7	%			4.5	%							11.7	%
Six months ended April 30, 2023
Net sales		$	309,955			$	118,715			$	108,192			$	(1,411	)		$	535,451
Cost of sales			247,189				78,155				91,787				(610	)			416,521
Gross Margin			62,766				40,560				16,405				(801	)			118,930
Gross Margin %			20.3	%			34.2	%			15.2	%							22.2	%
Selling, general and administrative(1)			27,453				15,957				10,844				9,861				64,115
Depreciation and amortization			10,295				4,701				5,904				176				21,076
Operating income (loss)			25,018				19,902				(343	)			(10,838	)			33,739
Depreciation and amortization			10,295				4,701				5,904				176				21,076
EBITDA			35,313				24,603				5,561				(10,662	)			54,815
Loss on damage to manufacturing facilities (Cost of sales)			35				-				13				-				48
Loss on damage to manufacturing facilities (SG&A)			-				-				200				-				200
Transaction and advisory fees			-				-				-				5,311				5,311
Adjusted EBITDA		$	35,348			$	24,603			$	5,774			$	(5,351	)		$	60,374
Adjusted EBITDA Margin %			11.4	%			20.7	%			5.3	%							11.3	%
(1) Includes stock-based compensation expense for the three and six months ended April 30, 2024, respectively of $1.5 million and $4.1 million and $0.4 million and $5.2 million for the comparable prior year periods.

QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
		Three Months Ended April 30,								Six Months Ended April 30,
		2024				2023				2024				2023
NA Fenestration:
	United States - fenestration	$	119,646			$	120,756			$	231,280			$	241,523
	International - fenestration		7,465				8,350				13,609				13,477
	United States - non-fenestration		27,532				24,334				53,323				47,400
	International - non-fenestration		5,131				3,535				9,557				7,555
		$	159,774			$	156,975			$	307,769			$	309,955
EU Fenestration:(1)
	International - fenestration	$	46,968			$	47,903			$	88,719			$	90,257
	International - non-fenestration		9,615				15,860				17,301				28,458
		$	56,583			$	63,763			$	106,020			$	118,715
NA Cabinet Components:
	United States - fenestration	$	3,737			$	4,219			$	7,412			$	8,127
	United States - non-fenestration		46,990				48,526				86,169				98,575
	International - non-fenestration		351				773				634				1,490
		$	51,078			$	53,518			$	94,215			$	108,192
Unallocated Corporate & Other:
	Eliminations	$	(1,234	)		$	(721	)		$	(2,648	)		$	(1,411	)
		$	(1,234	)		$	(721	)		$	(2,648	)		$	(1,411	)
Net Sales		$	266,201			$	273,535			$	505,356			$	535,451
(1) Reflects an increase of $0.6 million and $1.6 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2024, respectively.

FAQ

What were Quanex Building Products' Q2 2024 net sales?

Quanex Building Products reported net sales of $266.2 million for Q2 2024.

What was Quanex Building Products' net income for Q2 2024?

Quanex Building Products’ net income for Q2 2024 was $15.4 million.

How did Quanex Building Products' diluted EPS perform in Q2 2024?

Quanex Building Products' diluted EPS in Q2 2024 was $0.46, down from $0.65 in Q2 2023.

Did Quanex Building Products' Adjusted Net Income change in Q2 2024?

Quanex Building Products' Adjusted Net Income remained stable at $21.8 million in Q2 2024.

What guidance has Quanex Building Products provided for FY 2024?

Quanex Building Products reaffirmed its FY 2024 guidance, projecting net sales of approximately $1.1 billion and Adjusted EBITDA of $145-$150 million.

What was the performance of Quanex Building Products' North American Fenestration segment in Q2 2024?

Quanex Building Products' North American Fenestration segment saw a 1.8% increase in net sales in Q2 2024.

How did the European Fenestration segment perform for Quanex Building Products in Q2 2024?

Quanex Building Products' European Fenestration segment saw a net sales decrease of 10.4% in Q2 2024 due to lower volume and pricing pressure.